Defined Milestones
Six stages from sequence review to delivery
A practical route from sequence to application-ready protein
Request NowPROVETOP provides integrated protein expression and production services for universities, research institutes, biopharmaceutical companies and diagnostic developers. Projects can begin with a sequence, accession number or target name.
We evaluate molecular weight, domain boundaries, transmembrane regions, signal peptides, disulfide bonds, post-translational modifications and downstream use before recommending a construct, host, tag, purification route and quality package.
Available routes include E. coli, mammalian and insect-cell expression, with other systems evaluated when required. Project records and milestone communication are included throughout the service.
Six stages from sequence review to delivery
Target name, accession or complete sequence
E. coli, mammalian and insect-cell routes
Construct, host, tag, buffer and QC by use
| Milestones | Specifications | Deliverables | Indicative Time |
|---|---|---|---|
| Sequence Analysis & Plan |
| Feasibility feedback and recommended project route | 1–3 business days |
| Gene & Vector Construction |
| Sequence-confirmed expression construct | 2–3 weeks |
| Expression Evaluation |
| Small-scale screening summary and scale-up recommendation | 1–3 weeks |
| Scale-up & Purification |
| Purified protein sample and buffer record | 1–3 weeks |
| QC & Delivery |
| Sample, agreed QC report, project records and handling guidance | 3–7 business days |
| Turnaround Time | Typical cycle: 3–8 weeks. Difficult proteins and assay development are evaluated individually. | ||
Custom requirements may extend the turnaround time. Final timing is confirmed after technical evaluation.
A human receptor extracellular domain for antibody screening and interaction studies, with multiple glycosylation sites and disulfide bonds.
Domain-boundary and secretion-construct design, mammalian transient expression, affinity purification and SEC polishing.
A high-purity, homogeneous target protein suitable for downstream antibody binding and molecular-interaction studies.



A low-yield antigen produced mainly as inclusion bodies, requiring a sample suitable for animal immunization.
Adjust expression boundaries and tag position, screen strain, induction temperature and time, then compare soluble-expression and refolding routes.
Improved soluble expression and a purified sample suitable for the agreed downstream immunization work.


A recombinant cytokine with cellular activity for cell culture and in-vitro functional studies, with endotoxin control.
Secreted eukaryotic expression, multi-step purification, aggregation and endotoxin control, followed by a cell-based activity assay.
A sample meeting the agreed purity, endotoxin and biological-activity requirements for downstream cell experiments.


Share the protein target, intended use, quantity and quality requirements so we can prepare a project route and quotation.
Thank you. Our team will review your inquiry and follow up by email.